SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $617,400 | +45.9% | 30,000 | +233.3% | 0.00% | 0.0% |
| Q2 2023 | $423,180 | -13.9% | 9,000 | -23.2% | 0.00% | -33.3% |
| Q1 2023 | $491,561 | -85.3% | 11,715 | -86.7% | 0.00% | -85.0% |
| Q4 2022 | $3,350,408 | -13.7% | 87,845 | -11.4% | 0.02% | +25.0% |
| Q3 2022 | $3,881,000 | +817.1% | 99,100 | +1001.1% | 0.02% | +1500.0% |
| Q2 2022 | $423,180 | -20.2% | 9,000 | +22.6% | 0.00% | -50.0% |
| Q4 2019 | $530,000 | -13.1% | 7,341 | +68.9% | 0.00% | -50.0% |
| Q3 2019 | $610,000 | -21.4% | 4,347 | +2.5% | 0.00% | -20.0% |
| Q2 2019 | $776,000 | +9.8% | 4,241 | -4.6% | 0.01% | +25.0% |
| Q1 2019 | $707,000 | +42.3% | 4,447 | -14.3% | 0.00% | +33.3% |
| Q4 2018 | $497,000 | +4.9% | 5,192 | +54.8% | 0.00% | +50.0% |
| Q3 2018 | $474,000 | – | 3,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |